Sascha Berger of TVM Capital: Analyzing the Life-Science Landscape in the US and Europe

**Title**: **A Perspective on the Life Science Ecosystem: Interview with Sascha Berger, Partner at TVM Capital**

**Description**:

In this episode, join us as we have an enlightening conversation with Dr. Sascha Berger, Partner at TVM Capital, a pioneer transatlantic Life Science Venture Capital fund. Discover the evolution of the life science ecosystems in Europe and the United States and gain insights into TVM Capital’s unique investment approach. Learn how entrepreneurs can effectively reach out to venture capitalists and navigate the complex world of life science investments.

Dr. Sascha Berger, a passionate venture capitalist with a background in chemistry and finance, joined TVM Capital in 2016. He has played a crucial role in raising the current $480M fund and works closely with entrepreneurs and founders to advance promising pharmaceutical assets, MedTech, diagnostic, and digital health technologies.

TVM Capital, a dedicated life science venture capital firm with teams in Europe and North America, has been investing in entrepreneurial venture-backed companies since its inception. With a multi-stage investment approach, TVM Capital supports companies at various stages, from discovery to market-ready, as well as profitable companies seeking growth capital. Their investment focus spans therapeutics, technology platforms, MedTech, and diagnostics.

In this episode, we dive deep into various topics, including:

– The evolution of the life science ecosystems in the US and Europe
– TVM Capital’s unique investment approach
– Strategies for entrepreneurs to effectively reach out to VCs
– Long-term investment models in the life science industry
– Cultural differences between North America and Europe
– Creating companies that become targets for venture capitalists
– The importance of growth potential for TVM Capital
– Timeframe and process of VC investment decisions
– The right time for entrepreneurs to reach out to VCs

Don’t miss this insightful conversation with Dr. Sascha Berger, an expert in life science venture capital. If you’re interested in the future of the life science industry and how to navigate the world of venture capital, this episode is a must-watch!

**Links**:
– LinkedIn Profile: [Sascha Berger](https://www.linkedin.com/in/sasber/)
– TVM Capital Official Website: [TVM Capital](https://www.tvm-lifescience.com/)
– Shownotes: [Read Here](https://lsg2g.substack.com/p/59-a-perspective-on-the-life-science)
– Podcast Episode: [Listen Here](https://pod.link/1493847125/episode/268c3ae53ce51ab65d4a00cb1da261f4)

**Timestamps**:
– 00:00) Intro
– (02:30) The History of TVM Capital
– (05:45) The Development of Life Science Ecosystems in Europe and North America
– (10:35) Possibilities for Founders to Move their Companies Forward – From the Investors’ Perspective
– (13:45) Long-Term Investment Models in the Life Science Industry
– (17:40) Cultural Differences between North America and Europe
– (23:50) Creating Companies That Become Targets for VCs
– (27:10) Importance of Growth Potential for TVM Capital
– (29:05) Timeframe for VC Processes
– (33:35) Right Time to Reach out to VCs

**Stay Connected and Strengthen the Community**:
1. Like the video
2. Comment and share your ideas with fellow viewers.
3. Subscribe to the channel for more informative content.

**Other Channels**:
– [Subscribe to the Podcast](https://lsg2g.substack.com/subscribe)
– [Podcast Episodes](https://beginnersmind.buzzsprout.com/)
– [Episodes on YouTube](https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV)
– [Community Partner](https://linktr.ee/lsg2g)
– [Christian Soschner](https://linktr.ee/soschner)

**Connect with LSG2G**:
– [Twitter](https://twitter.com/LGet2gether)
– [LinkedIn](https://www.linkedin.com/company/life-science-get2gether)
– [Podcast Website](https://www.lifescienceget2gether.com/)

**Financial Disclaimer**:
This channel is intended for informational purposes and sharing expert tips and investment insights. We do not provide financial advice. Please consult a licensed financial advisor and conduct independent research before making any investment decisions. We encourage you to do your due diligence and never invest solely based on social media content or recommendations.

**Keywords/Tags**: *Sascha Berger, TVM Capital, Life Science, Investment, Investing, Christian Soschner, CS Life Science Invest, LSG2G, mRNA, Biontech, Moderna, Pfizer*

In this episode, I am having a conversation with Sascha Berger, Partner at TVM Capital.

Dr. Sascha Berger is a Partner at TVM Capital, based in Munich, Germany. TVM Capital is one of the pioneer transatlantic Life Science Venture Capital funds with Europe and North America teams. Sascha joined TVM Capital in 2016, helped raise the current $480M fund, and works closely with entrepreneurs and founders to advance promising pharmaceutical assets, MedTech, diagnostic, and digital health technologies to the following value inflection points. Sascha is a passionate VC, a Boston Consulting Group alumnus, and has an academic chemistry and finance background.

TVM Capital is a dedicated life science venture capital firm with Europe and North America teams. Since its inception, TVM Capital has invested in entrepreneurial venture-backed companies. Over several fund generations, TVM Capital’s investment strategy has included a multi-stage investment approach spanning discovery to market-ready companies as well as profitable companies searching for growth capital. The investment focus has always been broad and includes investments in therapeutics, technology platforms, MedTech, and diagnostics.

In this episode, we talk about

➡️ How the Life Science Eco-Systems evolved in the US and Europe
➡️ TVM Capitals Investment Approach
➡️ How to reach out to VCs
➡️ And much more…

I hope you enjoy the conversation the same way as I did.

Who is the Expert in the show?
➡️ Sascha Berger https://www.linkedin.com/in/sasber/
➡️ TVM Capital https://www.tvm-lifescience.com/

Shownotes: https://lsg2g.substack.com/p/59-a-perspective-on-the-life-science

Podcast Episode: https://pod.link/1493847125/episode/268c3ae53ce51ab65d4a00cb1da261f4

Timestamps:
00:00) Intro
(02:30) The History of TVM Capital
(05:45) The Development of Life Science Eco-Systems in Europe and North America
(10:35) What Possibilities Do Founders Have Today to Move their Companies Forward – From the Investors Perspective
(13:45) Long Term Investment Models in the Life Science Industry
(17:40) Cultural Differences between North America and Europe
(23:50) How to Create Companies That Become Targets for VCs
(27:10) How Important is the Growth Potential of a Company for TVM?
(29:05) How Much Time do VC Processes Take?
(33:35) When is the Right Time to Reach out to VCs?

▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
STRENGTHEN THE COMMUNITY
1. Like the video
2. Comment. If you have great stuff to share with other viewers, I love to see people discussing these ideas!
3. Subscribe. The more subscribers, the more content we can make!

LINKS TO MY OTHER CHANNELS:
If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe

Podcast Episodes: https://beginnersmind.buzzsprout.com/
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Website: https://www.lifescienceget2gether.com/

👉 FINANCIAL DISCLAIMER
This channel is intended to share tips and investment videos by experts. We DO NOT GIVE FINANCIAL ADVICE! Please consult a licensed financial advisor and do your own research before taking any economic action.

Never buy assets just because you saw someone on social media talking about it. Always do your own independent research before investing in any asset.
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬